FDA
-
-
-
-
-
-
-
DIAGNOS Strengthens Governance and Leadership with the Appointment of Philippe Couillard as Chairman of the Board of Directors
-
-
-
-
-
-
-
DIAGNOS to File for FDA Pre-Market Authorization of Its AI-Powered CARA SYSTEM and Engages Ora as Regulatory Specialist
-
-
-
-
-
-
-
DIAGNOS Announces Grant of Stock Options
-
-
-
-
-
-
-
DIAGNOS Announces the Deployment of its Age-Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual Group
-
-
-
-
-
-
-
DIAGNOS Successfully Completes ISO / MDSAP Audit
-
-
-
-
-
-
-
DIAGNOS Announces Voting Results of Annual Meeting of Shareholders
-
-
-
-
-
-
-
DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE
-
327,061 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

